The National Center for Advancing Translational Sciences (NCATS) is a part of the NIH, with a mission to catalyze the generation of innovative methods and technologies that will enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. (NCATS) would like to acquire services from Reaction to test 100 compounds against select kinases in a cellular NanoBret Assay.